Clinical Trial Update: Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer [Phase 2]

View source ↗

Summary

This clinical trial update summarizes a Phase 2 study of trastuzumab in patients with advanced salivary gland cancer, which has completed enrollment/status. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Salivary Gland Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED